Long-term amiodarone therapy: a cause of increased hepatic attenuation on CT
- 1 July 1984
- journal article
- research article
- Published by Oxford University Press (OUP) in The British Journal of Radiology
- Vol. 57 (679) , 573-576
- https://doi.org/10.1259/0007-1285-57-679-573
Abstract
Approximately 40% of the antiarrhythmic drug, amiodarone, consists of iodine. During long-term therapy [in humans], both the drug and its major metabolite, desethylamiodarone, are deposited in the liver. CT scans of patients receiving such therapy demonstrated increased hepatic attenuation.This publication has 5 references indexed in Scilit:
- High-performance liquid chromatographic measurement of amiodarone and desethylamiodarone in small tissue samples after enzymatic digestion.Journal of Clinical Pathology, 1983
- Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias.Circulation, 1983
- Side effects of long-term amiodarone therapy.Circulation, 1983
- Computed Tomography of the Liver and Kidneys in Glycogen Storage DiseaseJournal of Computer Assisted Tomography, 1982
- Computed Tomographic Analysis of Beta-Thalassemic Syndromes with HemochromatosisJournal of Computer Assisted Tomography, 1980